RecruitingNCT00006150

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)


Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment

600 participants

Start Date

Aug 10, 2000

Study Type

OBSERVATIONAL

Conditions

Summary

The Hyper IgE Syndromes (HIES) are primary immunodeficiencies resulting in eczema and recurrent skin and lung infections. Autosomal dominant Hyper IgE syndrome (AD-HIIES; Job's syndrome) is caused by STAT3 mutations, and is a multi-system disorder with skeletal, vascular, and connective tissue manifestations. Understanding how STAT3 mutations cause these diverse clinical manifestations is critical to our complete understanding of bone metabolism, bronchiectasis, dental maturation, and atherosclerosis. Bi-allelic mutations in DOCK8 cause a combined immunodeficiency previously described as autosomal-recessive Hyper IgE syndrome. These individuals suffer from extensive viral infections as well as have a high incidence of malignancy and mortality. The pathogenesis of this disease and long-term natural history is being investigated. Therefore, we seek to enroll patients and families with a confirmed or suspected diagnosis of HIES syndrome for extensive phenotypic and genotypic study as well as disease management. Patients will be carefully examined by a multidisciplinary team and followed longitudinally. Through these studies we hope to better characterize the clinical presentation of STAT3-mutated HIES, DOCK8 deficiency and other causes of the hyper IgE phenotype, and to be able to identify further genetic etiologies, as well as understand the pathogenesis of HIES. We seek to enroll 300 patients and 300 relatives.


Eligibility

Min Age: 1 MonthMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This study is following people with Hyper-IgE Syndrome (HIES) — a rare immune deficiency that causes recurring skin and lung infections — to understand how it develops and how to manage it better. **You may be eligible if...** - You have been referred to NIH with a diagnosis or suspicion of Hyper-IgE syndrome - You have another immune deficiency with features similar to HIES - Affected patients must be at least 1 month old; unaffected relatives must be 2 years or older - You are an unaffected biological relative of someone with HIES **You may NOT be eligible if...** - You are under 30 years old or have kidney problems or contrast dye allergies (for the CT heart imaging portion of the study only) - You have a medical or psychiatric condition that would make participation unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00006150


Related Trials